● Recruiting

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Condition: Geographic Atrophy Secondary to Age-related Macular Degeneration · Sponsor: Novartis Pharmaceuticals

PhasePhase 2

Planned participants272

Who can joinAll sexes, 50 Years to no upper limit

Healthy volunteersNo

About this study

To characterize the dose response relationship of FWY003 in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals · 1-888-669-6682 · novartis.email@novartis.com

Novartis Pharmaceuticals · +41613241111

Always discuss trial participation with your own doctor first.

Locations (51)

Salehi Retina Institute	Huntington Beach, California, United States	Recruiting
Retinal Consultants Medical Group Inc	Sacramento, California, United States	Recruiting
California Retina Consultants	Santa Barbara, California, United States	Recruiting
Advanced Research LLC	Boynton Beach, Florida, United States	Recruiting
Advanced Research LLC	Deerfield Beach, Florida, United States	Recruiting
Retina Vitreous Associates of Florida	St. Petersburg, Florida, United States	Recruiting
Opthamalic Consultants of Boston	Boston, Massachusetts, United States	Recruiting
NJ Retina	Toms River, New Jersey, United States	Recruiting
New York Eye and Ear Infirmary of Mount Sinai	New York, New York, United States	Recruiting
Columbia University Medical Center	New York, New York, United States	Recruiting
Erie Retina Research LLC	Erie, Pennsylvania, United States	Recruiting
Mid Atlantic Retina	Philadelphia, Pennsylvania, United States	Recruiting

+ 39 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07441642